Morgane Gossez Selected Research

HLA-DR Antigens (HLA-DR)

4/2022	HLA-DR expression on monocytes and outcome of anti-CD19 CAR-T cell therapy for large B-cell lymphoma.
4/2022	T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19.
3/2022
2/2021	[Study of monocytic myeloid-derived suppressor cells and CD4 lymphopenia in septic shock-induced immunosuppression].
12/2020	Monocyte HLA-DR Measurement by Flow Cytometry in COVID-19 Patients: An Interim Review.
1/2020	Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes.
12/2018	Sepsis is associated with lack of monocyte HLA-DR expression recovery without modulating T-cell reconstitution after lung transplantation.
11/2018	Proof of concept study of mass cytometry in septic shock patients reveals novel immune alterations.
11/2018	Massive increase in monocyte HLA-DR expression can be used to discriminate between septic shock and hemophagocytic lymphohistiocytosis-induced shock.
1/2018	CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Morgane Gossez Research Topics

Disease

10	Septic Shock (Toxic Shock Syndrome) 01/2020 - 01/2017
9	Sepsis (Septicemia) 03/2022 - 01/2018
7	COVID-19 04/2022 - 01/2020
6	Critical Illness (Critically Ill) 04/2022 - 01/2020
4	Infections 01/2021 - 01/2018
2	Lymphopenia (Lymphocytopenia) 04/2022 - 02/2021
2	Neoplasms (Cancer) 01/2022 - 01/2018
2	Shock 02/2021 - 11/2018
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2020 - 11/2018
2	HIV Infections (HIV Infection) 01/2019 - 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2022
1	Fatty Liver 04/2022
1	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 04/2022
1	Disease Progression 01/2019
1	Viremia 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2015
1	Dermatomyositis (Dermatopolymyositis) 06/2015

Drug/Important Bio-Agent (IBA)

10	HLA-DR Antigens (HLA-DR)IBA 04/2022 - 01/2018
5	Interleukin-7 (Interleukin 7)IBA 04/2022 - 01/2018
3	CytokinesIBA 01/2020 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
3	Immunologic Adjuvants (Immunologic Adjuvant)IBA 04/2019 - 01/2017
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 03/2018
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2018
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2019 - 11/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2018
1	LDL CholesterolIBA 04/2022
1	ApolipoproteinsIBA 04/2022
1	Apolipoproteins B (ApoB)IBA 04/2022
1	Nonsense Codon (Nonsense Mutation)IBA 04/2022
1	Oxidized LDL ReceptorsIBA 01/2022
1	LectinsIBA 01/2022
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2021
1	AntigensIBA 12/2019
1	Messenger RNA (mRNA)IBA 04/2019
1	Proteins (Proteins, Gene)FDA Link 04/2019
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	AutoantibodiesIBA 06/2015

Therapy/Procedure

1	Immunomodulation 03/2022
1	Art Therapy 01/2019
1	Aftercare (After-Treatment) 01/2019
1	Lung Transplantation 12/2018
1	Immunotherapy 11/2018
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Therapeutics 01/2017